Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UW Withdraw From Tobacco Study
NCT04969198Phase 2Completed
- Sponsor
- University of Wisconsin–Madison
- Start
- Jul 2021
- Primary completion
- Sep 2022
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of nicotine patch in tobacco dependence, sponsored by University of Wisconsin–Madison. Primary endpoints: Wisconsin Smoking Withdrawal Scale 2 Long at 2 weeks and Wisconsin Smoking Withdrawal Scale 2 Brief at 2 weeks. Started Jul 2021; status: completed.
02
Drugs
nicotine patch
03
Conditions
tobacco dependence
Beyond the preview
Go deeper on NCT04969198.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04969198.